Long-term efficacy and safety of ruxolitinib versus best...

  • Main
  • 2020 / 1
  • Long-term efficacy and safety of ruxolitinib versus best...
The Lancet Haematology 2020 / 1

Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study

Kiladjian, Jean-Jacques, Zachee, Pierre, Hino, Masayuki, Pane, Fabrizio, Masszi, Tamas, Harrison, Claire N, Mesa, Ruben, Miller, Carole B, Passamonti, Francesco, Durrant, Simon, Griesshammer, Martin,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Lancet Haematology
DOI:
10.1016/S2352-3026(19)30207-8
Date:
January, 2020
File:
PDF, 1.29 MB
english, 2020
Conversion to is in progress
Conversion to is failed